Some La Roche-Posay, Proactiv and Walgreens acne treatments recalled due to benzene levels
U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government ...
Roche secures Zealand obesity drug candidate for up to $5.3 billion
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...
Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal
The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...
Why La Roche-Posay is pulling this acne treatment, and why you shouldn't use it
Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing ...
Fierce Pharma1d
Roche settles UPenn suit alleging patent infringement by Herceptin, 3 other breast cancer meds
Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...
GEN - Genetic Engineering and Biotechnology News3d
Roche, Zealand Launch Up-to-$5.3B Obesity Collaboration
Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...
La Roche-Posay, Proactiv, Walgreens skin care products voluntarily recalled over potentially cancer-causing chemical
Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to elevated levels of a potentially cancer-causing agent.
LAist22h
Some acne treatments from brands like Walgreens and La Roche-Posay voluntarily recalled
Some acne treatments from brands including Walgreens, Proactiv and La-Roche Posay have been voluntarily recalled for ...
Fierce Biotech3d
Roche pads out obesity pipeline, paying Zealand $1.6B upfront to codevelop amylin asset
Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...